| Literature DB >> 15746548 |
Abstract
As a clinical entity, myasthenia gravis was not recognized until Samuel Wilks in 1877 described bulbar and peripheral muscular weakness. In the Lancet of June 2, 1934, the remarkable discovery of physostigmine treatment by Dr. Mary Walker was published, which was to become the mainstay of symptomatic treatment. A quiet and modest physician, she laboured with considerable success under many obstacles in her work and career. Copyright (c) 2005 S. Karger AG, Basel.Entities:
Mesh：
Substances：
Year: 2005 PMID： 15746548 DOI： 10.1159/000084268
Source DB: PubMed Journal: Eur Neurol ISSN： 0014-3022 Impact factor: 1.710